Treatt Plc · LSE:TET

Treatt — FY2021 Earnings Presentation

29 slides from Treatt's earnings presentation, November 2021

  1. Slide 1: Final Results for the Year Ended 30 September 2021

    FINAL RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2021 Daemmon Reeve — Chief Executive Officer Richard Hope — Chief Financial Officer

  2. Slide 2: Disclaimer

    A DISCLAIMER UTREATT This presentation has been prepared for information purposes only, and does not constitute an offer of securities or otherwise constitute an invitation or inducement to any person to underwrite, subscribe for or otherwise acquire securities in Treatt plc or any of its subsidiary

  3. Slide 3: Record Performance on All Key Metrics

    A RECORD PERFORMANCE ON ALL KEY METRICS DIEU £124.3m 34.0% £20.9m Revenue’ Gross Margin Profit Before Tax’? +14.0% +480bps +41.3% 27.05p 7.50p 20.9% Earnings Per Share*2 Full Year Dividend Return on Average 437.2% +25.0% Capital Employed? +240bps

  4. Slide 4: Remarkable Performance

    REMARKABLE PERFORMANCE ¢ Strong performance driven by growth in addressable markets * Profit before tax'? materially exceeding initial expectations * No material impact from global supply chain issues * Margin growth led by healthier living categories * Navigating COVID-19 including operational chal

  5. Slide 5: Growth - Innovation and Consumer Trends

    GROWTH - INNOVATION AND CONSUMER TRENDS A op TREATT Diversifying across growing addressable markets RTD Cocktails continue to win market share - partnering with many of the world’s leading brands Continuing demand for natural, better-for-you products Promising opportunities from new coffee platform

  6. Slide 6: ESG - It's in Our DNA

    ESG - IT’S IN OUR DNA STRATEGY: PROGRESSING OUR PRIORITIES: + Further embed sustainability - the lens through * Mapping our sustainable supply chain strategy which we view our business * Review purpose, values and behaviours to support * To explore opportunities and mitigate risks in sustainability

  7. Slide 7: Financial Review

    dp TREATT FINANCIAL REVIEW

  8. Slide 8: Track Record of PBT Growth - 2021: +41.3%

    A TRACK RECORD OF PBT GROWTH - 2021: +41.3% ap TREATT PROFIT BEFORE TAX'2 £20.9m 50% £14.8m £12.7m £13.3m £11.7m 50% 46% 4T% 41% _ 41% 38% ” 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Traded Evolution from Traded to Added-Value » Added-Value 1 From continuing activities 2 Excluding exceptiona

  9. Slide 9: Dividend Per Share - 2021: +25.0%

    DIVIDEND PER SHARE - 2021: +25.0% A op TREATT 7.50p 6.00p 5.50p ne 5.10p 4.80p aga 3.50p 4.04p 4.35p ag 3.70p 3.84p We 2.76p 3.10p 2.60p 2.60p 2.08p 2.00p 1.45p 1.60p 1.70p 1.84p 1.28) 1.35p . 1.02p 1.10p 1.24p p 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021

  10. Slide 10: 2021 Financial Review

    2021 FINANCIAL REVIEW A op TREATT INCOME STATEMENT o 2 s © a a lo} 2 a= 2 < 5 is) Year Ended 30 September peoen co Change Revenue 124,326 109,016 14.0% Gross profit 42,223 31,876 32.5% Gross profit margin 34.0% 29.2% 480bps Administrative expenses (20,877) (16,784) (24.4%) Operating profit 21,346 15

  11. Slide 11: Cash Flow

    CASH FLOW A op TREATT £30.0m £25.0m £23.9m. £20.0m £15.0m £10.0m £5.0m £0.4m £0.0m (£5.0m) (£10.0m) (£15.0m) Net Cash YE Operating 2020 Cash Flow * Strong underlying cash performance * Working capital increase - prudent levels of inventory to mitigate supply chain risk (£10.0m) (£9.5m) (£4.9m) (£4.9

  12. Slide 12: Strong Growth in Higher Margin Categories

    STRONG GROWTH IN HIGHER MARGIN CATEGORIES A op TREATT % OF REVENUE 2021 Health & Wellness 7.1% (2020: 6.8%) Citrus Herbs, Spices & Florals 9.3% (2020: 10.6%) Fruit & Vegetables 10.2% (2020: 7.3%) Tea 11.0% (2020: 5.9%) Synthetic Aroma 18.2% (2020: 19.1%) 43.6% (2020: 50.3%) % Growth % of Category 20

  13. Slide 13: Revenue: +14.0%

    REVENUE: +14.0% PROGRESS IN BOTH ROUTES TO MARKET STRONG GROWTH IN MAJOR TERRITORIES! ge an 2021 2021 WDirect to Brand Owners —«@ Flavour Houses BUnited States +22% Gest of the World -11% GEurope +18% UK +28% @The Americas +22% @China +8% 3B From continuing activities The Americas (excluding the US)

  14. Slide 14: Strategic Evolution - Moving Up the Value Chain

    N STRATEGIC EVOLUTION Uy TREATT MOVING UP THE VALUE CHAIN . Continued progress in shift away from traded activities Sales: Added-Value v Traded * Citrus becoming a more added-value category - reduced dependency on traded and minimally-processed citrus * Science and manufacturing technologies and IP

  15. Slide 15: Financial Metrics

    FINANCIAL METRICS A op TREATT Net Operating Margin * Increased from 12.4% to 17.2% over the last 5 years * Target range: 15% - 20% Return On Average Capital Employed (ROACE) * 2017: 10% Placing to fund investment * 2021: Investment in US now yielding results * ROACE for FY 2021 - 21.0% * Target rang

  16. Slide 16: Market Overview, Strategic Priorities

    dp TREATT MARKET OVERVIEW STRATEGIC PRIORITIES

  17. Slide 17: Healthier Lifestyles

    HEALTHIER LIFESTYLES L TRUST THROUGH TRANSPARENCY Evolution from energy drinks to ‘natural’ functional Pandemic accelerating trend Segment witnessing exponential growth Ingredient transparency paramount Clean label ingredient market forecast 85% of consumers to grow at a CAGR of 6.7% globally say th

  18. Slide 18: Accessing Market Growth Opportunities

    A ACCESSING MARKET GROWTH OPPORTUNITIES UP TREATT INNOVATION IN READY TO DRINK AND FUNCTIONAL BEVERAGE MARKETS RTD COFFEE Global market value forecast to grow to $18.9bn by 2026 - 14.2% increase from 2020 Cold brew driving growth and premiumisation Hybrid beverage trends New drinking occasions, flav

  19. Slide 19: Benefits of the New UK Site

    BENEFITS OF THE NEW UK SITE CAPACITY, EFFICIENCY, INNOVATION AND COLLABORATION * Transfer complete by mid-2023 * Capacity - materially higher volumes possible + Efficiency — optimal site logistics; moving from analogue to digital * Innovation — significantly expanded R&D labs * Client collaboration

  20. Slide 20: Current Trading & Outlook

    CURRENT TRADING & OUTLOOK ¢ Continued strong growth in revenue expected ¢ Material opportunities, including coffee * Momentum building in China ¢ Manufacturing underway at new UK facility from mid 2022 * Capital Markets Day - Friday 21%* January 2022 ¢ Strengthening executive team to support growth:

  21. Slide 21: Thank You - Any Questions?

    A op TREATT THANK YOU Any QuEsTIONs? A u TREATT

  22. Slide 22: Appendices

    dp TREATT APPENDICES

  23. Slide 23: Product Categories

    Herbs, Spices & Florals Citrus Botanical ingredients are growing in With a strong and established popularity in several markets as background in citrus, our range of ‘naturalness’ continues to be an natural and synthetic products are increasing priority well aligned with consumer tastes ‘Synthetic A

  24. Slide 24: Partnership Model

    PARTNERSHIP MODEL TREATT Top 10 Customers Ranking by Revenue FY21 Type of Products No. Years asa Customer Categories Ranking by Revenue FY16 KEY Type of Products: Flavour Fragrance Alcoholic Beverage Non-Alcoholic Beverage Consumer Goods Distributor Categories: Citrus ) Tea 0) Health & Wellness S))

  25. Slide 25: 2021 Cash Flow

    2021 CASH FLOW Year Ended 30 September peoen coo Operating cash flow 23,940 15,902 Increase in inventories (11,851) (458) Increase in receivables (2,680) (1,278) Increase in payables 4483 1,511 Cash generated from operations 13,892 15,677 Contributions to pension scheme (450) (300) Taxation paid (4,

  26. Slide 26: 2021 Balance Sheet

    2021 BALANCE SHEET Year Ended 30 September 2021 2020 Fixed assets £65.0m £52.7m Inventories £47.3m £36.1m Receivables £26.4m £24.2m Payables (£17.0rm) (£12.4m) Working capital £56.7m £47.9m, Taxation £1.3m £0.1m Net (debt)/cash (£9.1m) £0.4m Pension deficit (£6.8m) (£10.1m) Other net (liabilities)/a

  27. Slide 27: Earnings Per Share

    EARNINGS PER SHARE' o TREATT 19.72p 18.02p 17.82p 11.649 16.41 P 9.44p 9.47p 9.83p 8.58p 8.35p 8.08p 6.58p 2017 2018 2019 2020 1 From continuing activities 27.05p

  28. Slide 28: Investment Infrastructure Phase Timeline

    > A A INVESTMENT INFRASTRUCTURE PHASE TIMELINE TREAT Initiated £48m Capital Investment Programme 2017 + Equity fund raise £20m US $15m Expansion Complete 2019 UK build complete (fit-out underway) 2020 Colleagues begin 2021 transition to new site Operations to commence at new site improved margin 202

  29. Slide 29: Treatt

    u TREATT

Treatt — FY2021 Earnings Presentation on 6ix